Deflazacort - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for deflazacort and what is the scope of patent protection?

Deflazacort is the generic ingredient in two branded drugs marketed by Tris Pharma Inc, Ptc Therap, Aurobindo Pharma Ltd, and Upsher Smith Labs, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for deflazacort. Three suppliers are listed for this compound.

Sponsor

Phase

Parc de Salut Mar

Phase 1

FibroGen

Phase 3

Catabasis Pharmaceuticals

Phase 1

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-001	Feb 9, 2017	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-002	Feb 9, 2017	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Upsher Smith Labs	DEFLAZACORT	deflazacort	TABLET;ORAL	216720-004	Nov 5, 2024	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Upsher Smith Labs	DEFLAZACORT	deflazacort	TABLET;ORAL	216720-001	Nov 5, 2024	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	2
Applicants:	4
NDAs:	5
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	75
Clinical Trials:	23
Patent Applications:	6,947
What excipients (inactive ingredients) are in deflazacort?	deflazacort excipients list
DailyMed Link:	deflazacort at DailyMed

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists